Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Rascase 1.5 mg Injection
Rascase 1.5 mg Injection
Manufacturer/Marketed By : Sayre Therapeutics Pvt Ltd
$119.67 $58.25
Rascase 1.5 mg Injection is an effective treatment designed to manage elevated uric acid levels in the bloodstream, a condition referred to as hyperuricemia. This medication is especially beneficial for...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Rasburicase 1.5 mg
Active Pharmaceutical Ingredient
Rascase 1.5 mg Injection
119,67 US$
58,25 US$
Rascase 1.5 mg Injection is an effective treatment designed to manage elevated uric acid levels in the bloodstream, a condition referred to as hyperuricemia. This medication is especially beneficial for patients receiving chemotherapy for specific cancers, including leukemia, lymphoma, and various solid tumors, as well as those at risk of tumor lysis syndrome (TLS), a serious complication that can arise during cancer treatment. Rascase functions by converting uric acid into allantoin, a more soluble substance that the kidneys can easily eliminate, thus preventing potential complications associated with high uric acid levels. It's crucial for patients to be aware of possible side effects, which may include allergic reactions or infusion-related symptoms, and to discuss any pre-existing health conditions with their healthcare provider prior to use. This injection is typically administered under medical supervision to ensure optimal safety and effectiveness. As a key player in cancer care, Rascase not only alleviates the risks of hyperuricemia but also supports overall treatment protocols, enhancing patient outcomes. Always consult with a healthcare professional for tailored advice and monitoring during treatment with Rascase.
Active Pharmaceutical Ingredient
Usos
• Rascase 1 5 mg injection is primarily used to manage hyperuricemia, particularly in patients undergoing chemotherapy. This condition can arise due to tumor lysis syndrome (TLS), where rapid cell breakdown leads to elevated uric acid levels. By administering Rascase 1 5 mg injection, healthcare providers can help reduce these levels effectively. This is crucial for preventing complications associated with high uric acid.
• In the context of chemotherapy, Rascase 1 5 mg injection plays a significant role in preventing the complications linked to TLS. As cancer cells break down during treatment, uric acid levels can spike, leading to potential kidney damage. Rascase 1 5 mg injection facilitates the reduction of uric acid, thereby protecting kidney function. This makes it an essential part of supportive care in oncology.
• Rascase 1 5 mg injection can be utilized in various clinical settings where hyperuricemia is a concern. Patients who experience rapid cell turnover, such as those with certain types of cancers, may benefit from this treatment. By administering Rascase 1 5 mg injection, healthcare professionals can manage uric acid levels more effectively. This intervention is particularly valuable during intensive chemotherapy regimens.
• The use of Rascase 1 5 mg injection is integral in the management of hyperuricemia during the treatment of malignancies. It aids in mitigating the risk of TLS, which can pose serious health challenges. By lowering uric acid levels, Rascase 1 5 mg injection helps maintain better metabolic balance in patients undergoing cancer therapy. This supportive measure enhances patient care and treatment outcomes.
Beneficios
Rascase 1.5 mg Injection is helpful for people who have to deal with too much uric acid, especially if they have certain types of cancer or are having chemotherapy. It works by lowering uric acid levels, which can relieve things like joint pain and swelling caused by too much uric acid in the body. It also helps to prevent problems such as kidney stones or damage caused by the formation of uric acid crystals. By tackling these problems, rasburicase helps people feel better overall and makes it easier for them to recover during treatment.
Efectos secundarios
Like all medicines, Rascase 1.5 mg Injection may cause side effects that do not require medical attention and will disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you're concerned about them.
Efectos secundarios más comunes
• Anxiety
• Fever
• Vomiting
• Joint pain
• Mouth sores/ulcers
• Swollen Limbs
• Injection site pain
Efectos secundarios comunes
• Yellowing Eyes
• Dark urine
• Bluish or Grey-coloured skin
• Injection site Pain
• Nausea
• Constipation
• Diarrhea
• Abdominal pain
• Throat pain
• Headche
Cómo utilizar
Using Rascase 1.5 mg Vial typically involves getting it through an intravenous (IV) infusion. A healthcare professional will administer it directly into your vein, usually in a hospital or clinic setting. The dosage and frequency of rasburicase injections will depend on your specific medical condition and your doctor's recommendations. It's essential to follow your healthcare provider's instructions carefully and attend all scheduled appointments for Rascase 1.5 mg treatment. They'll monitor your response to the medication and adjust your treatment plan as needed to ensure the best results and minimize any potential side effects.
Consejos de seguridad
• Alcohol: Consuming alcohol may affect the effectiveness of Rascase 1.5 mg. If you are taking rasburicase, it is recommended to stop consuming alcohol to ensure the medication works properly.
• Kidney: Rascase 1.5 mg Injection is safe for patients with kidney disease, and no dose adjustment is necessary. While taking Rascase 1.5 mg, regular monitoring of blood tests may be recommended to ensure optimal health and effective treatment.
• Breastfeeding: It is unknown if Rascase 1.5 mg Injection passes into breast milk or how it might affect your baby. Please consult your doctor before breastfeeding if you are receiving Rasburicase Injection 1.5 mg treatment.
• Liver: It is unknown whether Rascase 1.5 mg Injection can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with Rascase 1.5 mg.
• Pregnancy: It is unsafe to use Rascase 1.5 mg Injection during pregnancy. If you are pregnant or planning to become pregnant during the treatment, consult your doctor before taking Rascase 1.5 mg.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking Rasburicase Injection 1.5 mg because it contains a small amount of alcohol, which may cause dizziness and impair your concentration.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.